CN109125502A - Reducing blood lipid on behalf of the tea and preparation method thereof - Google Patents
Reducing blood lipid on behalf of the tea and preparation method thereof Download PDFInfo
- Publication number
- CN109125502A CN109125502A CN201811232080.8A CN201811232080A CN109125502A CN 109125502 A CN109125502 A CN 109125502A CN 201811232080 A CN201811232080 A CN 201811232080A CN 109125502 A CN109125502 A CN 109125502A
- Authority
- CN
- China
- Prior art keywords
- grams
- tea
- behalf
- blood lipid
- reducing blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provide reducing blood lipid on behalf of the tea and preparation method thereof, on behalf of the tea include following component: 50-100 grams of cassia seed in parts by mass, 50-100 grams of fig, 50-100 grams of fructus lycii, 80-110 grams of jujube, 10-50 grams of Radix Codonopsis, 10-30 grams of Radix Astragali, 5-15 grams of Radix Notoginseng, 8-12 grams of g of Siraitia grosvenorii, 6-13 grams of g of Cortex Eucommiae, 5-10 grams of rose, 4-6 grams of stevioside；Preparation method: prepare raw material cassia seed, fig, fructus lycii, jujube, Radix Codonopsis, Radix Astragali, Radix Notoginseng, Siraitia grosvenorii, Cortex Eucommiae and rose by above-mentioned mass parts, after cleaning up, pulverization process obtains mixed-powder；The mixed-powder is put in the water of above-mentioned component, boils extraction 25-30min, obtain leaching liquor；The stevioside of above-mentioned mass parts is added in the leaching liquor, after mixing evenly, filters on behalf of the tea.Reducing blood lipid of the invention provides a kind of new therapy approach on behalf of the tea, for hyperlipemic patients, and compared to the existing way for reducing blood lipid using Western medicine, stable effect is not easy to rebound, be free from side effects to human body, and drug cost is low.
Description
Technical field
The present invention relates to Chinese medicine health-care technical fields, and in particular to reducing blood lipid on behalf of the tea and preparation method thereof.
Background technique
In recent years, with the improvement of people ' s living standards and living-pattern preservation, the disease incidence of hyperlipidemia is on obvious
The trend of liter, hyperlipidemia is to lead to atherosclerosis, causes the principal element of serious cardiovascular and cerebrovascular disease, although the drop of Western medicine
Rouge effect is approved, but one side Western medicine is expensive, uninterrupted medication, is undoubtedly for average family very big negative
Load, and Western medicine exist be discontinued after easily rebound, easily generation myolysis, the drawbacks of the adverse reactions such as hepatic disorder.
Summary of the invention
In order to overcome the drawbacks of the prior art, the present invention provides reducing blood lipid on behalf of the tea, solves existing using Western medicine reduction
Medicine cost burden weight is bought caused by blood lipid, and rebound of being discontinued, take the defect for having side effect to human body, drop of the invention for a long time
Blood lipid on behalf of the tea, specifically includes following scheme:
Reducing blood lipid on behalf of the tea, in parts by mass, including following component: 50-100 grams of cassia seed, 50-100 grams of fig,
50-100 grams of fructus lycii, 80-110 grams of jujube, 10-50 grams of Radix Codonopsis, 10-30 grams of Radix Astragali, 5-15 grams of Radix Notoginseng, 8-12 grams of g of Siraitia grosvenorii, Du
Secondary 6-13 grams of g, 5-10 grams of rose, 4-6 grams of stevioside.
Including following component preferably, in parts by mass: 50-80 grams of cassia seed, 50-80 grams of fig, fructus lycii 50-100
Gram, 100-110 grams of jujube, 10-30 grams of Radix Codonopsis, 10-20 grams of Radix Astragali, 5-10 grams of Radix Notoginseng, Siraitia grosvenorii 8-10 grams of g, 6-10 grams of Cortex Eucommiae
G, 8-10 grams of rose, 5-6 grams of stevioside.
Including following component preferably, in parts by mass: 80 grams of cassia seed, 80 grams of fig, 100 grams of fructus lycii, jujube
100 grams, 10 grams of Radix Codonopsis, 10 grams of Radix Astragali, 10 grams of Radix Notoginseng, 10 grams of g of Siraitia grosvenorii, Cortex Eucommiae 10 grams of g, 10 grams of rose, 5 grams of stevioside.
It further, on behalf of the tea in parts by mass, further include 3-8 grams of composite dispersing agent, composite dispersing agent is by including Vitamin C
Acid, potassium sorbate and sodium alginate are constituted, in mass ratio, ascorbic acid: potassium sorbate: sodium alginate 2-5:1-3:4:6.
It further, on behalf of the tea in parts by mass, further include 1-3 parts of beta-cyclodextrin, 2-4 parts of lemon juice.
On behalf of the tea for above-mentioned reducing blood lipid, corresponding preparation method is provided, is specifically comprised the following steps:
(1) by above-mentioned mass parts prepare raw material cassia seed, fig, fructus lycii, jujube, Radix Codonopsis, Radix Astragali, Radix Notoginseng, Siraitia grosvenorii,
Cortex Eucommiae and rose, after cleaning up, pulverization process obtains mixed-powder；
(2) mixed-powder is put in the water of above-mentioned component, boils extraction 25-30min, obtains leaching liquor；
(3) stevioside of above-mentioned mass parts is added in the leaching liquor, after mixing evenly, filters on behalf of the tea.
Further, in the step (1), before crushing after raw material is cleaned, low temperature drying processing is carried out, low temperature drying
At -5 to -10 degrees Celsius, the time of low temperature drying is controlled in 0.5-1h for temperature control.
Further, in the step (2), raw material into the water further includes 3-8 grams of composite dispersing agent, composite dispersing agent
It is made of ascorbic acid, potassium sorbate and sodium alginate, in mass ratio, ascorbic acid: potassium sorbate: sodium alginate 2-5:1-
3:4:6.
Further, in the step (3), the raw material being added in leaching liquor further includes 1-3 parts of beta-cyclodextrin, lemon juice 2-
4 parts.
Further, further include step (4), will be obtained by filtration on behalf of the tea with independent package bag filling and sealing, obtain bag
Dress is on behalf of the tea.
Compared with the nearest prior art, technical solution of the present invention have it is following the utility model has the advantages that
The present invention using cassia seed, fig, Radix Codonopsis, Radix Astragali, Radix Notoginseng, Siraitia grosvenorii and Cortex Eucommiae as monarch drug in a prescription, with fructus lycii, jujube and
Rose is ministerial drug, using stevioside as harmonizing drug, obtains reducing blood lipid on behalf of the tea, provides a kind of new treatment for hyperlipemic patients
Approach is had stable effect, is not easy to rebound, be free from side effects to human body compared to the existing way for being reduced blood lipid using Western medicine,
And the low beneficial effect of drug cost.
Reducing blood lipid of the invention further comprises being made of ascorbic acid, potassium sorbate and sodium alginate on behalf of the tea
Composite dispersing agent, composite dispersing agent in the leaching process of preparation process on behalf of the tea, the effect of effectively facilitating each component the factor
Rapid dispersion reduces the time of extraction into water, improves the efficiency for preparing finished product on behalf of the tea.
Reducing blood lipid of the invention on behalf of the tea, further comprises 1-3 parts of beta-cyclodextrin, 2-4 parts of lemon juice, is making on behalf of the tea
During standby, the taste of traditional Chinese medicine of tea-drinking is on the one hand adsorbed, improves herbal tea mouthfeel, on the other hand stablizes each component on behalf of the tea,
Prevent precipitating from generating.
The present invention is in reducing blood lipid preparation process on behalf of the tea, before crushing to raw material, carries out low temperature drying processing,
It has been effectively retained the integrality of the effective component in raw material.
Of the invention can filling be on behalf of the tea independent packaging, carry convenient for office worker.
Specific embodiment
Below in conjunction with specific embodiment, technical solution of the present invention is clearly and completely described.Based on the present invention
In embodiment, every other implementation obtained by those of ordinary skill in the art without making creative efforts
Example, shall fall within the protection scope of the present invention.
Embodiment 1
Reducing blood lipid on behalf of the tea, in parts by mass, including following component: 50 grams of cassia seed, 50 grams of fig, fructus lycii 50
Gram, 80 grams of jujube, 10 grams of Radix Codonopsis, 10 grams of Radix Astragali, 5 grams of Radix Notoginseng, 8 grams of g of Siraitia grosvenorii, Cortex Eucommiae 6 grams of g, 5 grams of rose, stevioside 4
Gram.
The preparation method on behalf of the tea of the reducing blood lipid of the present embodiment, specifically comprises the following steps:
(1) prepare raw material cassia seed, fig, fructus lycii, jujube, Radix Codonopsis 1, Radix Astragali, Radix Notoginseng, arhat by above-mentioned mass parts
Fruit, Cortex Eucommiae and rose, after cleaning up, pulverization process obtains mixed-powder；
(2) mixed-powder is put in the water of above-mentioned component, boils extraction 25-30min, obtains leaching liquor；
(3) stevioside of above-mentioned mass parts is added in the leaching liquor, after mixing evenly, filters on behalf of the tea.
Embodiment 2
Reducing blood lipid on behalf of the tea, in parts by mass, including following component: 100 grams of cassia seed, 100 grams of fig, fructus lycii
100 grams, 110 grams of jujube, 50 grams of Radix Codonopsis, 30 grams of Radix Astragali, 15 grams of Radix Notoginseng, 12 grams of g of Siraitia grosvenorii, Cortex Eucommiae 13 grams of g, 10 grams of rose,
6 grams of stevioside.
The reducing blood lipid of the present embodiment the preparation method is the same as that of Example 1 on behalf of the tea.
Embodiment 3
Reducing blood lipid on behalf of the tea, in parts by mass, including following component: 80 grams of cassia seed, 80 grams of fig, fructus lycii 60
Gram, 110 grams of jujube, 30 grams of Radix Codonopsis, 20 grams of Radix Astragali, 5 grams of Radix Notoginseng, 8 grams of g of Siraitia grosvenorii, Cortex Eucommiae 6 grams of g, 8 grams of rose, stevioside 6
Gram.
The reducing blood lipid of the present embodiment the preparation method is the same as that of Example 1 on behalf of the tea.
Embodiment 4
Reducing blood lipid on behalf of the tea, in parts by mass, including following component: 80 grams of cassia seed, 80 grams of fig, fructus lycii 100
Gram, 100 grams of jujube, 10 grams of Radix Codonopsis, 10 grams of Radix Astragali, 10 grams of Radix Notoginseng, 10 grams of g of Siraitia grosvenorii, Cortex Eucommiae 10 grams of g, 10 grams of rose, stevia rebaudianum
5 grams of sugar.
The reducing blood lipid of the present embodiment the preparation method is the same as that of Example 1 on behalf of the tea.
Embodiment 5
On behalf of the tea, on the basis of embodiment 1, component further comprises: composite dispersing agent for the reducing blood lipid of the present embodiment
3-8 grams, composite dispersing agent is constituted by including ascorbic acid, potassium sorbate and sodium alginate, in mass ratio, ascorbic acid: sorbic acid
Potassium: sodium alginate 2-5:1-3:4:6, it is preferred that ascorbic acid: potassium sorbate: sodium alginate 3:2:5.
The preparation method on behalf of the tea of the reducing blood lipid of the present embodiment, specifically comprises the following steps:
(1) prepare raw material cassia seed, fig, fructus lycii, jujube, Radix Codonopsis 1, Radix Astragali, Radix Notoginseng, arhat by above-mentioned mass parts
Fruit, Cortex Eucommiae and rose, after cleaning up, pulverization process obtains mixed-powder；
(2) mixed-powder and composite dispersing agent are put in the water of above-mentioned component, boil extraction 25-30min, must soaks
Extract；
(3) stevioside of above-mentioned mass parts is added in the leaching liquor, after mixing evenly, filters on behalf of the tea.
Embodiment 6
On behalf of the tea, on the basis of embodiment 1, component further comprises: beta-cyclodextrin 1-3 for the reducing blood lipid of the present embodiment
Part, 2-4 parts of lemon juice.
The preparation method on behalf of the tea of the reducing blood lipid of the present embodiment, specifically comprises the following steps:
(1) prepare raw material cassia seed, fig, fructus lycii, jujube, Radix Codonopsis 1, Radix Astragali, Radix Notoginseng, arhat by above-mentioned mass parts
Fruit, Cortex Eucommiae and rose, after cleaning up, pulverization process obtains mixed-powder；
(2) mixed-powder is put in the water of above-mentioned component, boils extraction 25-30min, obtains leaching liquor；
(3) stevioside and beta-cyclodextrin and lemon juice of above-mentioned mass parts are added in the leaching liquor, after mixing evenly,
Filter on behalf of the tea.
Embodiment 7
On behalf of the tea, material component and embodiment 1 are identical, and difference is for the reducing blood lipid of the present embodiment, the drop of the present embodiment
The preparation method on behalf of the tea of blood lipid in step (1), before crushing after raw material is cleaned, carries out low on the basis of embodiment 1
Temperature is dried, and at -5 to -10 degrees Celsius, the time of low temperature drying is controlled in 0.5-1h for the temperature control of low temperature drying.
Embodiment 8
On behalf of the tea, material component and embodiment 1 are identical, and difference is for the reducing blood lipid of the present embodiment, the drop of the present embodiment
The preparation method on behalf of the tea of blood lipid further includes on the basis of embodiment 1 step (4), will be obtained by filtration on behalf of the tea with only
Vertical packaging bag filling and sealing, obtain it is packed on behalf of the tea, carried convenient for office worker.
Below on behalf of the tea to the embodiment of the present invention 1, following performance test is done to its effect for reducing blood fat to measure:
1, experimental animal, Kunming SPF grades of male mice 60 for choosing health, is divided into two groups, every group 30；
2, experimental animal model is established:
First group is used as blank control group, feeding normal diet and drinking water, until off-test, normal diet, that is, commercially available
Feed；
Second group of feeding high lipid food and drinking water, the formula of high lipid food: basal feed 50%, lard 27%, sucrose
20%, yolk powder 3%；After feeding four weeks, the chain urea of 120mg/kg is injected intraperitoneally in second group of mouse fasting 12h (can't help water)
Rhzomorph to be helped, then proceedes to feeding 10 days, mouse fasting 12h, tail vein takes hematometry mouse fasting plasma value, blood glucose value >=
Simultaneously there are more drinks in 11.1mmol/L, and the mouse of diuresis symptom is chosen to be type-2 diabetes mellitus model mice, in 30 mouse, wherein
24 model successfully；
3, after the completion of modeling, blood lipids index, measurement result such as the following table 1 are measured to two groups of mouse respectively
Table 1
4, feeding is raised
Twoth group of mouse according to the form below 2 is raised into feeding:
Table 2
| Project | Feed | Stomach-filling |
| First group of mouse | Normal diet | Water |
| Second group of mouse | High lipid food | The embodiment of the present invention 1 is on behalf of the tea |
5, after feeding 10 days by upper table 2, fasting 12h carries out blood lipids index measurement, measurement result such as following table to two groups of mouse
3
Table 3
By contrast table 1 and table 3 it can be learnt that: the mouse of the stomach-filling embodiment of the present invention 1 on behalf of the tea is relative to blank control
Although the mouse blood lipid value of group is still increased, compared to the mouse before stomach-filling on behalf of the tea, the blood lipid value of mouse is significantly reduced.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, any
Those familiar with the art in the technical scope disclosed by the present invention, can easily think of the change or the replacement, and should all contain
Lid is within protection scope of the present invention.Therefore, protection scope of the present invention should be based on the protection scope of the described claims.
Claims (10)
1. reducing blood lipid is on behalf of the tea, which is characterized in that in parts by mass, including following component: 50-100 grams of cassia seed, fig
50-100 grams, 50-100 grams of fructus lycii, 80-110 grams of jujube, 10-50 grams of Radix Codonopsis, 10-30 grams of Radix Astragali, 5-15 grams of Radix Notoginseng, Siraitia grosvenorii
8-12 grams of g, Cortex Eucommiae 6-13 grams of g, 5-10 grams of rose, 4-6 grams of stevioside.
2. reducing blood lipid according to claim 1 is on behalf of the tea, which is characterized in that in parts by mass, including following component: certainly
50-80 grams of pine torch, 50-80 grams of fig, 50-100 grams of fructus lycii, 100-110 grams of jujube, 10-30 grams of Radix Codonopsis, 10-20 grams of Radix Astragali,
5-10 grams of Radix Notoginseng, 8-10 grams of g of Siraitia grosvenorii, Cortex Eucommiae 6-10 grams of g, 8-10 grams of rose, 5-6 grams of stevioside.
3. reducing blood lipid according to claim 1 is on behalf of the tea, which is characterized in that in parts by mass, including following component: certainly
80 grams of pine torch, 80 grams of fig, 100 grams of fructus lycii, 100 grams of jujube, 10 grams of Radix Codonopsis, 10 grams of Radix Astragali, 10 grams of Radix Notoginseng, 10 grams of Siraitia grosvenorii
G, Cortex Eucommiae 10 grams of g, 10 grams of rose, 5 grams of stevioside.
4. reducing blood lipid according to claim 1 is on behalf of the tea, which is characterized in that further include composite diffusion in parts by mass
3-8 grams of agent, composite dispersing agent is made of ascorbic acid, potassium sorbate and sodium alginate, in mass ratio, ascorbic acid: sorbic acid
Potassium: sodium alginate 2-5:1-3:4:6.
5. reducing blood lipid according to claim 1 is on behalf of the tea, which is characterized in that further include beta-cyclodextrin in parts by mass
1-3 parts, 2-4 parts of lemon juice.
6. the preparation method on behalf of the tea of reducing blood lipid according to claim 1 to 3, which comprises the steps of:
(1) prepare raw material cassia seed, fig, fructus lycii, jujube, Radix Codonopsis, Radix Astragali, Radix Notoginseng, Siraitia grosvenorii, Cortex Eucommiae by above-mentioned mass parts
And rose, after cleaning up, pulverization process obtains mixed-powder；
(2) mixed-powder is put in the water of above-mentioned component, boils extraction 25-30min, obtains leaching liquor；
(3) stevioside of above-mentioned mass parts is added in the leaching liquor, after mixing evenly, filters on behalf of the tea.
7. the preparation method on behalf of the tea of reducing blood lipid according to claim 6, which is characterized in that, will in the step (1)
Before crushing after raw material cleaning, low temperature drying processing is carried out, the temperature control of low temperature drying is at -5 to -10 degrees Celsius, low temperature drying
Time control in 0.5-1h.
8. the preparation method on behalf of the tea of reducing blood lipid according to claim 6, which is characterized in that in the step (2), put
Entering the raw material in water further includes 3-8 grams of composite dispersing agent, and composite dispersing agent is by ascorbic acid, potassium sorbate and sodium alginate structure
At, in mass ratio, ascorbic acid: potassium sorbate: sodium alginate 2-5:1-3:4:6.
9. the preparation method on behalf of the tea of reducing blood lipid according to claim 6, which is characterized in that in the step (3), leaching
The raw material being added in extract further includes 1-3 parts of beta-cyclodextrin, 2-4 parts of lemon juice.
10. the preparation method on behalf of the tea of reducing blood lipid according to claim 6, which is characterized in that it further include step (4),
To be obtained by filtration on behalf of the tea with independent package bag filling and sealing, obtain it is packed on behalf of the tea.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811232080.8A CN109125502A (en) | 2018-10-22 | 2018-10-22 | Reducing blood lipid on behalf of the tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811232080.8A CN109125502A (en) | 2018-10-22 | 2018-10-22 | Reducing blood lipid on behalf of the tea and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109125502A true CN109125502A (en) | 2019-01-04 |
Family
ID=64809306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811232080.8A Pending CN109125502A (en) | 2018-10-22 | 2018-10-22 | Reducing blood lipid on behalf of the tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109125502A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101164608A (en) * | 2007-10-29 | 2008-04-23 | 王文生 | Traditional Chinese medicine composition for treating high blood pressure and preparation process thereof |
| CN101732510A (en) * | 2010-01-18 | 2010-06-16 | 深圳市千金方生物技术有限公司 | Lipid-lowering liver-protection tea and preparation method thereof |
| CN102106416A (en) * | 2009-12-28 | 2011-06-29 | 蔡灵艳 | Formula of refreshing tea |
| CN102138601A (en) * | 2010-11-16 | 2011-08-03 | 苏州市天灵中药饮片有限公司 | Beauty-maintaining tea and preparation process thereof |
| CN106900929A (en) * | 2015-12-22 | 2017-06-30 | 焦秀英 | Defatting tea with Chinese herbal medicines |
-
2018
- 2018-10-22 CN CN201811232080.8A patent/CN109125502A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101164608A (en) * | 2007-10-29 | 2008-04-23 | 王文生 | Traditional Chinese medicine composition for treating high blood pressure and preparation process thereof |
| CN102106416A (en) * | 2009-12-28 | 2011-06-29 | 蔡灵艳 | Formula of refreshing tea |
| CN101732510A (en) * | 2010-01-18 | 2010-06-16 | 深圳市千金方生物技术有限公司 | Lipid-lowering liver-protection tea and preparation method thereof |
| CN102138601A (en) * | 2010-11-16 | 2011-08-03 | 苏州市天灵中药饮片有限公司 | Beauty-maintaining tea and preparation process thereof |
| CN106900929A (en) * | 2015-12-22 | 2017-06-30 | 焦秀英 | Defatting tea with Chinese herbal medicines |
Non-Patent Citations (2)
| Title |
|---|
| 刘春生 等: "《精编＜本草纲目＞药物彩色图鉴》", 31 January 2016, 山西科学技术出版社 * |
| 白鸿: "《保健食品功效成分检测方法》", 31 May 2011, 中国中医药出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386110B (en) | Chinese medicine composition, and preparation method and applications thereof | |
| CN102284005A (en) | Preparation method of sealwort and longan paste | |
| CN103960568B (en) | A kind of general ginsenoside chewable tablets and preparation method thereof | |
| CN103735687B (en) | A kind of Weight reducing compound and preparation method thereof | |
| CN102987383A (en) | Total nutrient composition for balancing intestinal flora structure and improving metabolic syndrome and application thereof | |
| CN103520551B (en) | A kind of damp-heat constitution health food and preparation method thereof | |
| CN102524665A (en) | Processing method of rhizoma polygonati noodles | |
| CN102396623A (en) | Ginger-containing alcloholism relieving instant beverage and preparation method thereof | |
| CN105341597A (en) | Beverage rich in cereal dietary fibers and preparation method | |
| CN101715910B (en) | Composition of banana oligosaccharide and dietary fibre, preparation method and application thereof | |
| CN101926891A (en) | Composition for losing weight | |
| CN105456622A (en) | Traditional Chinese medicinal composition for treating impaired glucose regulation, preparation, and preparation method thereof | |
| CN108112973A (en) | A kind of auxiliary lower hyperlipidemia, hypertension, hyperglycemia composition and preparation method thereof | |
| CN102283935A (en) | Preparation method of herba leonuri and longan paste | |
| CN106723015A (en) | A kind of health food and its preparation technology with antifatigue and anti-oxidation function | |
| CN102429059B (en) | Ginger-containing dealcoholic instant drink and preparation method thereof | |
| CN109045098A (en) | A kind of lower hyperlipidemia, hypertension, hyperglycemia lozenge and preparation method thereof | |
| CN102488052B (en) | Inflatedfruit senna seed instant nutritious coffee powder and coffee for losing weight and reducing fat, pressure and sugar, and production process thereof | |
| CN102949629A (en) | Health care tea for helping digestion and strengthening stomach | |
| CN104888046B (en) | A kind of herbal health care oral liquid for having effects that improve anaemia | |
| CN109125502A (en) | Reducing blood lipid on behalf of the tea and preparation method thereof | |
| CN102038857B (en) | Method for preparing Chinese medicinal composition for treating child dyspepsia caused by overeating | |
| CN102488045A (en) | Inflatedfruit senna seed electuary for losing weight and reducing pressure and sugar, and production process thereof | |
| CN102389540A (en) | Calcium gluconate oral solution with effect of strengthening the spleen and stomach | |
| CN102132884A (en) | Preparation method of foods, beverages and medicines containing apocynum venetum extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190104 |
|
| RJ01 | Rejection of invention patent application after publication |